I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
This will be a phase 1a randomized, open label, multi-center study with approximately 24 subjects. All subjects will receive standard of care (SOC) per institutional guidelines for treatment of hospitalized patients with COVID-19 infection. In addition to SOC, the brequinar group will receive 5 daily doses of brequinar 100 mg.
gastrointestinal symptoms
acute respiratory syndrome (sars)
throat
coronavirus infection
sore throat
- 0 views
- 19 Feb, 2024
CoV-ICU Score Intensive Care Unit SARS-CoV-2
We aim to find an answer to the question of whether the patient's CRP, ferritin, D-dimer, Oxygen Saturation, lymphocyte count, and body mass index can be used as a criterion for admitting patients with COVID to the intensive see unit.
- 0 views
- 19 Feb, 2024